Samy Tadros
Corporate Officer/Principal chez TANGO THERAPEUTICS, INC.
Profil
Samy Tadros is currently the Head of Business Development at Tango Therapeutics, Inc. He previously worked as the Executive Director of Business Development at Celgene Corp.
Tadros has an undergraduate degree from Concordia University Chicago, an MBA from Fairleigh Dickinson University, and a graduate degree from Temple University School of Pharmacy.
Postes actifs de Samy Tadros
| Sociétés | Poste | Début |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Samy Tadros
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Formation de Samy Tadros
| Concordia University Chicago | Undergraduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TANGO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
